CureVac N.V.
CureVac N.V. (CVAC) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CVAC · as of Sep 30, 2025
Ownership Breakdown
98
Institutional Holders
▲ 4 vs Q2
$105.43M
Total Inst. Value
▲ $42.94M vs Q2
225.17M
Shares Outstanding
freeFloat 42.64%
19.57M
13F Shares Held
▲ 8.05M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CVAC largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
GLAZER CAPITAL, LLC pharmaceutical preparations | 4.55M | 2.02% | 2.02% | $24.51B | Nov 13, 2025 | ▲ 3.95M |
ALPINE ASSOCIATES MANAGEMENT INC. pharmaceutical preparations | 2.30M | 1.02% | 1.02% | $12.37B | Nov 6, 2025 | ▲ 324.2K |
QUBE RESEARCH & TECHNOLOGIES LTD pharmaceutical preparations | 1.71M | 76.06% | 76.06% | $9.23B | Nov 14, 2025 | ▲ 530.7K |
BLACKROCK, INC. pharmaceutical preparations | 1.02M | 45.13% | 45.13% | $5.48B | Nov 12, 2025 | ▼ 14.0K |
AQR ARBITRAGE LLC pharmaceutical preparations | 991.7K | 44.04% | 44.04% | $5.35B | Nov 14, 2025 | ▲ 947.5K |
WATER ISLAND CAPITAL LLC pharmaceutical preparations | 762.1K | 33.85% | 33.85% | $4.11B | Nov 14, 2025 | ▼ 194.9K |
MAGNETAR FINANCIAL LLC pharmaceutical preparations | 654.8K | 29.08% | 29.08% | $3.53B | Nov 13, 2025 | NEW |
ROYAL BANK OF CANADA pharmaceutical preparations | 501.6K | 22.28% | 22.28% | $2.70B | Nov 14, 2025 | ▲ 492.0K |
BRIDGEWATER ASSOCIATES, LP pharmaceutical preparations | 466.4K | 20.71% | 20.71% | $2.51B | Nov 13, 2025 | NEW |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 443.3K | 19.69% | 19.69% | $2.39B | Feb 3, 2026 | ▲ 347.9K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
19
Increased
+7.49M shares8
New Positions
first time holders15
Decreased
−690.8K shares0
Sold Out
fully exitedNet shares change (top 50)
+6.80M
+7.49M / −690.8K
Net new holders
+12
8 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CVAC insider trading · insider activity
Source: SEC Form 4
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
CureVac N.V. (CVAC) is primarily owned by institutional investors, who hold approximately 8.7% of total shares outstanding. Company insiders own approximately 57.36%, while retail and public investors account for the remaining 33.95%.
The largest institutional shareholder of CureVac N.V. is GLAZER CAPITAL, LLC, holding approximately 4.55 million shares — equal to 2.02% of outstanding shares — as of September 30, 2025.
A total of 98 institutional investors currently hold CVAC stock, with a combined institutional value of approximately $105,428,086 as of the most recent 13F filing period.
Frequently asked questions
CVAC ownershipCureVac N.V. (CVAC) is primarily owned by institutional investors, who hold approximately 8.7% of shares. The largest shareholder is GLAZER CAPITAL, LLC with a 2.02% stake. Company insiders hold 57.36%. Data sourced from SEC Form 13F as of September 30, 2025.